Chaitanya Tatineni

Chaitanya Tatineni has extensive experience in the healthcare investment banking sector and corporate leadership. Currently serving as CEO of International Markets and Chief M&A Officer at Curium Pharma since September 2016, Chaitanya oversees strategic alliances and licensing efforts. Prior experience includes a role as Vice President at Jefferies from June 2013 to September 2016, Associate positions in healthcare investment banking at Merrill Lynch and ABN AMRO Bank N.V., and initial experience on the M&A Execution Team at ABN AMRO Hong Kong. Chaitanya holds an MBA in Finance from the Indian Institute of Management Ahmedabad, completed an exchange program at ESCP Business School, and earned a Bachelor in Technology in Electronics and Communication Engineering from the Indian Institute of Technology, Kharagpur.